Viridian Therapeutics Inc (NAS:VRDN)
$ 11.95 0.01 (0.08%) Market Cap: 762.68 Mil Enterprise Value: 369.62 Mil PE Ratio: 0 PB Ratio: 1.99 GF Score: 44/100

Viridian Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 03, 2021 / 04:00PM GMT
Release Date Price: $16.6 (-5.31%)
Operator

Hello, everyone. Welcome to the Viridian Therapeutics, Inc. 2021 Annual Meeting of Stockholders. I will now pass the call to Jonathan Violin.

Jonathan Violin
Viridian Therapeutics, Inc. - CEO, President & Director

Good morning. I'm Jonathan Violin, and I'm the President, Chief Executive Officer and a Director of Viridian Therapeutics. I'm very happy to welcome you to the Viridian Therapeutics 2021 Annual Stockholders' meeting. Since the meeting is being held virtually via live webcast, we have stockholders attending via web portal. Before I call the meeting to order, I'd like to introduce you to the members of the Board and the business team who are with us today. The other members of the Board are Jeff Hatfield, Chair President of our Board; Peter Harwin, Tomas Kiselak, Arlene Morris and Joseph Turner. Mr. Hatfield and Mr. Turner will not be standing for reelection at today's annual meeting, and we'd like to take this opportunity to thank them for their service to the company.

The other members of our business team here today are Lara Meisner,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot